Last fight of wild polio in Africa: Nigeria’s battle

Adebisi, Yusuff Adebayo; Lucero‐Prisno, Don Eliseo; Nuga, Boyiga Bodinga

doi:10.1016/j.puhip.2020.100043

Cited by 12 publications

(13 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Another multi-national study in Europe revealed that more than half said they were concerned about the potential side effects of the vaccine [23]. This is not surprising in that all these findings have been found in literature as some of the reasons for vaccine hesitancy [31,32]. It has also been documented in the literature that vaccine adoption is a sum of vaccine access and acceptance [33].…”

Section: Discussionmentioning

confidence: 99%

When it is available, will we take it? Public perception of hypothetical COVID-19 vaccine in Nigeria

Adebisi

Alaran

Bolarinwa

et al. 2020

Preprint

Self Cite

View full text Add to dashboard Cite

COVID-19 pandemic is a global public health threat facing mankind. There is no specific antiviral treatment for COVID-19, and no vaccine is currently available. This study aims to understand the perception of the public towards hypothetical COVID-19 vaccine in Nigeria. We conducted a cross-sectional survey in August 2020 across the 36 states of Nigeria using an online questionnaire. The questionnaire includes sections on the demographic characteristics of the respondents and their perception regarding hypothetical COVID-19 vaccine. A total of 517 respondents completed and returned the informed consent along with the questionnaire electronically. Data were coded and abstracted into the Microsoft Excel spreadsheet and loaded into the STATA 14 software for final analysis. The results showed that more than half of the respondents were male 294 (56.87%). Most of the respondents (385, 74.47%) intend to take the COVID-19 vaccine when it becomes available. Among the 132 respondents that would not take the COVID-19 vaccine, the major reason for non-acceptance is unreliability of the clinical trials 49 (37.12%), followed by the belief that their immune system is sufficient to combat the virus 36 (27.27%). There are significant association with the respondents age and having reservations toward vaccination [χ2= 19.0389 P-value=0.00] and COVID-19 vaccine acceptance [χ2=24.3316 P-value=0.00]. Furthermore, geographical location and acceptance of the COVID-19 vaccine [χ2=13.7786 P-value=0.02] are significantly associated. Even though the majority of our respondents are willing to take the COVID-19 vaccine, our findings reiterate the need to reassure the public that any vaccine which becomes available is safe and effective.

show abstract

Section: Discussionmentioning

confidence: 99%

When it is available, will we take it? Public perception of hypothetical COVID-19 vaccine in Nigeria

Adebisi

Alaran

Bolarinwa

et al. 2020

Preprint

Self Cite

View full text Add to dashboard Cite

show abstract

“…Vaccination is an important public health tool and one of the most important advances in healthcare in the fight against infectious diseases [22]. It is responsible for the eradication of rinderpest and smallpox and the control of infectious diseases such as polio in many parts of the world [23]. It is therefore clear that a safe, highly effective, and globally acceptable and equitable vaccination program, together with pre-existing precautionary measures, is essential to effectively contain the outbreak [24].…”

Section: Discussionmentioning

confidence: 99%

Willingness to Vaccinate against COVID-19 among Healthcare Workers: An Online Survey in 10 Countries in the Eastern Mediterranean Region

Elhadi

Mehanna

Adebisi

et al. 2021

Preprint

Self Cite

View full text Add to dashboard Cite

Background: Healthcare workers intention to be vaccinated is an important factor to be consider for successful COVID-19 vaccination programme. Our study aimed to understand the intention of health workers to receive COVID-19 vaccine and associated concerns across 10 countries in Eastern Mediterranean Region (EMRO). Method: A cross-sectional study was conducted in January 2021 among healthcare workers using an online survey. A total of 2806 health workers (physicians, nurses and pharmacists) completed and returned the informed consent along with the questionnaire electronically. Data were analyzed using IBM SPSS software package version 20.0. Results: More than half of the respondents (58.0%) intend to receive COVID-19 vaccine, even if the vaccination is not mandatory for them. On the other hand, 25.7% of respondents were not intending to undertake COVID-19 vaccination while 16.3 % answered undecided. The top three reasons for not intending to be vaccinated were unreliability of COVID-19 vaccine clinical trials (62.0%), fear of the side effects of the vaccine (45.3%), and that COVID-19 vaccine will not give immunity for a long period of time (23.1%). Conclusion: Overall, our study revealed suboptimal acceptance of COVID-19 vaccine among healthcare workers in the 10 countries in EMRO.

show abstract

“…As an effective public health tool, vaccines have been shown to be the most successful measures for saving millions of lives against disease threat, especially when they are implemented and carried out as programs effectively. 3,4 In different countries of the world, vaccines have been the most effective measures in reducing morbidity and deaths associated with some diseases, especially killer diseases of children, for example, polio. Amid the responses of African governments to COVID-19, 5 there have been efforts toward the production of a vaccine for the disease in some countries.…”

Section: Current Efforts On Vaccinementioning

confidence: 99%

“…This drags these poor nations out of the list of priorities by the donor countries. 8 The recent legacy of Africa in eradicating polio 3 shows the achievement of the continent's health systems from the interventions. Over the years, there have been records of increased number of trained health workers, social mobilizers, laboratorians, and vaccinators for polio.…”

Section: Who Will Pay For Africa?mentioning

confidence: 99%

“…Similar achievement recorded in polio eradication in Africa can be achieved in a shorter period of time. 3 The recent assembly of wealthy nations in COVAX should aim at promoting inclusion and equitable access to the vaccine for all African nations. 6 In addition, the vulnerable, underrepresented, and the marginalized populations must not be forgotten in the vaccination program.…”

Section: Recommendationsmentioning

confidence: 99%

See 1 more Smart Citation

Who Will Pay for the COVID-19 Vaccines for Africa?

Lucero‐Prisno

Ogunkola

Imo

et al. 2021

The American Journal of Tropical Medicine and Hygiene

Self Cite

View full text Add to dashboard Cite

Africa’s health systems are strained by the COVID-19 pandemic. There are global efforts toward the development and trial of COVID-19 vaccines. However, considering the challenges and economic conditions of African nations, there could be limited access and availability of the vaccines on the continent. This will be the result of high cost and technical requirements to acquire the vaccines. There are indications that possible donor funding for COVID-19 vaccines from rich countries maybe put off considering the various challenges they face currently and the moves they are making in response to the disease. The issue of justice in health for protecting the vulnerable populations and regions also supports the need for COVID-19 vaccine availability on the African continent. Means to achieve uniform control of the disease burden across the globe should be adopted. Governments of African nations should also scale up their efforts toward COVID-19 vaccine acquisition and utilization through viable efforts. It is therefore important to assist the African continent in acquiring the COVID-19 vaccines by leveling all power dynamics that will affect access and distribution.

show abstract

Last fight of wild polio in Africa: Nigeria’s battle

Cited by 12 publications

References 2 publications

When it is available, will we take it? Public perception of hypothetical COVID-19 vaccine in Nigeria

When it is available, will we take it? Public perception of hypothetical COVID-19 vaccine in Nigeria

Willingness to Vaccinate against COVID-19 among Healthcare Workers: An Online Survey in 10 Countries in the Eastern Mediterranean Region

Who Will Pay for the COVID-19 Vaccines for Africa?

Contact Info

Product

Resources

About